This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
1 Oct 2013

Unlocking the Potential of Cell Delivery Agents

Link Technologies Ltd, an ISO 9001:2008 certified specialist oligonucleotide reagent manufacturer, will be presenting a poster at the upcoming 9th Annual Meeting of the Oligonucleotide Therapeutic Society (OTS), 6–8 October, Naples, Italy.

The poster entitled ‘New Potential Oligonucleotide Delivery Reagents’, details how Link Technologies’ novel modifiers can enable the enhanced delivery of oligos for therapeutic effect. Inspired by their existing collection of lipophilic modifiers, which have been proven to enhance cell penetration, Link Technologies has developed this new collection of modified phosphoramidites, and are inviting collaborative partners to help discover their full application potential. At OTS, Dr Catherine McKeen, Technical Manager at Link Technologies, will be on-hand throughout the poster presentation sessions to provide further information and answer any questions.

Related News